Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/29/2012US20120302572 Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment
11/29/2012US20120302571 CRYSTALLINE FORMS OF (S)-1-(4-(5-CYCLOPROPYL-1H-PYRAZOL-3-YLAMINO)PYRROLO[1,2-f][1,2,4]TRIAZIN-2-YL)-N-(6-FLUOROPYRIDIN-3-YL)-2-METHYLPYRROLIDINE-2-CARBOXAMIDE
11/29/2012US20120302570 Heterocyclic oxime compounds
11/29/2012US20120302569 Phenyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation
11/29/2012US20120302568 Sigma ligands for use in the prevention and/or treatment of post-operative pain
11/29/2012US20120302567 Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase
11/29/2012US20120302566 Indanyloxydihydrobenzofuranylacetic acids
11/29/2012US20120302565 Kinase inhibitors for preventing or treating pathogen infection and method of use thereof
11/29/2012US20120302564 (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
11/29/2012US20120302563 Substituted norindenoisoquinolines, syntheses thereof, and methods of use
11/29/2012US20120302562 4h-thieno[3,2-c]chromene-based inhibitors of notum pectinacetylesterase and methods of their use
11/29/2012US20120302561 Compounds, Formulations, and Methods of Protein Kinase C Inhibition
11/29/2012US20120302560 Novel Benzoic Pyrrolopyridine Derivatives
11/29/2012US20120302558 Oxazine derivatives and their use in the treatment of neurological disorders
11/29/2012US20120302557 Biologically active methylene blue derivatives
11/29/2012US20120302556 Antiviral Compounds
11/29/2012US20120302555 Method of treatment using eprosartan
11/29/2012US20120302554 Phantom phenomena treatment
11/29/2012US20120302553 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
11/29/2012US20120302552 S-mirtazapine for the treatment of hot flush
11/29/2012US20120302551 Thiolactams and uses thereof
11/29/2012US20120302550 Salts and polymorphs of 8-fluoro-2--1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
11/29/2012US20120302549 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
11/29/2012US20120302548 2-arylimidazole derivatives as pde10a enzyme inhibitors
11/29/2012US20120302547 Novel mch receptor antagonists
11/29/2012US20120302546 Novel sulfamides exhibiting neuroprotective action and methods for use thereof
11/29/2012US20120302545 Method of Using PI3K and MEK Modulators
11/29/2012US20120302544 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
11/29/2012US20120302543 Compounds for the Treatment of Neurological Disorders
11/29/2012US20120302542 Monobactams
11/29/2012US20120302541 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
11/29/2012US20120302540 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
11/29/2012US20120302539 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/29/2012US20120302538 Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
11/29/2012US20120302537 Treatment methods using pharmaceutical solid state forms
11/29/2012US20120302536 Use of DHEA Derivatives for Enhancing Physical Performance
11/29/2012US20120302535 Progesterone treatment for improving sleep quality
11/29/2012US20120302534 Derivatives of betulin
11/29/2012US20120302533 Derivatives of pyrimido [6,1-a] isoquinolin-4-one
11/29/2012US20120302532 Combinations comprising antimuscarinic agents and corticosteroids
11/29/2012US20120302531 beta-2-Adrenoreceptor Agonists
11/29/2012US20120302530 23-hydroxy-betulinic acid derivatives, preparation methods and uses thereof
11/29/2012US20120302529 Method of treating actinic keratosis and basal cell carcinoma
11/29/2012US20120302528 Bioabsorbable polymer compositions exhibiting enhanced crystallization and hydrolysis rates
11/29/2012US20120302527 C7-Fluoro Substituted Tetracycline Compounds
11/29/2012US20120302526 Methods for treating post-traumatic stress disorder
11/29/2012US20120302525 Synthetic bile acid compositions and methods
11/29/2012US20120302524 1,3,4-oxadiazole-2-carboxamide compound
11/29/2012US20120302523 Endoperoxides and methods of photocatalytically synthesizing endoperoxides
11/29/2012US20120302522 Synergistic antiviral composition and use thereof
11/29/2012US20120302521 Inhibition of pancreatic lipase
11/29/2012US20120302520 Gemcitabine combination therapy
11/29/2012US20120302519 Multiple substituted fluoromethanes as selective and bioactive isosteres
11/29/2012US20120302518 Polymorphic Form Of N-(S)-(3,4-Difluoro-2-(2-Fluoro-4-Iodophenylamino)-6-Methoxyphenyl)-1-(2,3-Dihydroxypropyl)Cyclopropane-1-Sulfonamide And Uses Thereof
11/29/2012US20120302517 Tet2 as a new diagnostic and pronostic marker in hematopoietic neoplasms
11/29/2012US20120302516 Nanoparticles for drug delivery
11/29/2012US20120302515 Methods for producing phytoextracts from vegetation waters and olive oil pomaces and compositions obtained thereby
11/29/2012US20120302514 Glycoconjugates and methods
11/29/2012US20120302510 Histone deacetylases, and uses related thereto
11/29/2012US20120302491 Modulation of estrogen receptor-related receptor gamma (err gamma) and uses therefor
11/29/2012US20120301552 CaSR Antagonist
11/29/2012US20120301551 Compounds and compositions for treating neuronal death or neurological dysfunction
11/29/2012US20120301549 Complex formulation comprising aspirin coated with barrier containing hydrophobic additive, and hmg-coa reductase inhibitor
11/29/2012US20120301548 Oral complex composition comprising pseudoephedrine and levocetirizine
11/29/2012US20120301547 Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof
11/29/2012US20120301546 Acid-resistant soft gel compositions
11/29/2012US20120301544 Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
11/29/2012US20120301543 Suppository comprising pantoprazole
11/29/2012US20120301542 Extended release formulations of rasagiline and uses thereof
11/29/2012US20120301541 Compressed core for pharmaceutical composition
11/29/2012US20120301539 Method of producing coated fine particles
11/29/2012US20120301537 LIPOSOME CONTAINING shRNA MOLECULE TARGETING A THYMIDYLATE SYNTHASE AND USE THEREOF
11/29/2012US20120301527 Hair follicle targeting compositions
11/29/2012US20120301518 Biocompatible and biodegradable elastomeric polymers
11/29/2012US20120301517 Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
11/29/2012US20120301514 Development of bioactive electrospun coatings for biomedical applications
11/29/2012US20120301511 Topical formulation comprising a corticosteroid as active ingredient
11/29/2012US20120301509 Boldline compounds for promoting bone growth
11/29/2012US20120301508 Compositions for Induction of Osteogenesis around an Implant
11/29/2012US20120301505 Immunostimulating Agent and Method for Production Thereof
11/29/2012US20120301499 Packaging of Immunostimulatory Substances into Virus-Like Particles: Method of Preparation and Use
11/29/2012US20120301486 Compositions and methods for inhibition of the jak pathway
11/29/2012US20120301485 Juvenile Hemochromatosis Gene (HFE2A) Cleavage Products and Uses Thereof
11/29/2012US20120301479 Hendra virus recombinant compositions and uses thereof
11/29/2012US20120301478 Pharmaceutical for Preventing or Treating Disorders Accompanied by Ocular Angiogenesis and/or Elevated Ocular Vascular Permeability
11/29/2012US20120301477 USE OF CCR9, CCL25/TECK, AND INTEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE
11/29/2012US20120301470 Use of tyrosine kinase inhibitors for treatment of cushing's disease and hypercortisolism
11/29/2012US20120301464 Janus kinase inhibitors for treatment of dry eye and other eye related diseases
11/29/2012US20120301463 Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
11/29/2012US20120301458 Cyclopropyl modulators of p2y12 receptor
11/29/2012US20120301457 LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc
11/29/2012US20120301449 Rna interference target for treating aids
11/29/2012US20120301439 Inhibition of choroidal neovascularization
11/29/2012US20120301434 Antibacterial polypeptides and use thereof
11/29/2012US20120301430 Thiophene analogues for the treatment or prevention of flavivirus infections
11/29/2012US20120301427 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2012US20120301425 Novel antitumoral use of cabazitaxel
11/29/2012US20120301424 Cyclodextrin-based polymers for therapeutics delivery
11/29/2012US20120301422 Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances
11/29/2012US20120301408 Oral care methods and compositions utilizing chitosan-derivative compounds
1 ... 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 ... 7860